Connect with us

Hi, what are you looking for?


This Industry Group LOVES The Next 3 Months

Our research at includes extensive seasonal studies, working off the seasonality tool here at We’ve recently ended the best historical period of the year, which runs from the close on October 27th through the close on January 18th. But the bullishness doesn’t come to an end, it simply slows down. If you’re looking for market sectors that historically perform well for the next 3 months, keep an eye on technology (XLK) and materials (XLB). These two have been the most consistent outperforming sectors through May since this secular bull market began.

But how about an industry group that loves this time of year?

In my opinion, there is no single industry group that loves March through May quite like the specialty finance area ($DJUSSP). The following is the “relative” (vs. the benchmark S&P 500) seasonal performance by calendar month:

By adding up the monthly outperformance averages for each calendar month, we can quickly compute that the DJUSSP absolutely loves the first 7 months of the year. Here’s the outperformance of this group since the secular bull market began, broken down between the following two periods:

  • January through July: +11.2%
  • August through December: -1.6%

The sweet spot for specialty finance is March through May, however, as this 3-consecutive-month period has been its best, outperforming the S&P 500 by 5.4% on average since 2013!

Perhaps the best news of all is that I see significant technical improvement in the DJUSSP currently, as you can see from the chart below:

In addition to an obvious uptrend since October, relative strength kicked in almost immediately as the new year began. Though the entire pattern isn’t reflected above, the February weakness could represent a bottoming right shoulder in a reverse head & shoulders pattern that began during the second half of 2022. Clearing overhead price resistance at 520 on a closing basis would confirm the pattern.

At, we provide our members with 3 portfolios comprised of 10 equal-weighted stocks, designed to outperform the S&P 500 over a quarter. Then we select 10 more equal-weighted stocks for the next 3 months and so on and so on. Our Model Portfolio has crushed the benchmark S&P 500 since the Portfolio’s inception in November 2018 (+130.31% vs. +51.60%). We selected our latest portfolios at Friday’s close and I included a specialty finance stock as 1 of the 10 equal-weighted stocks in our Model Portfolio.

This specialty finance stock has outperformed the S&P 500, on average, by 17.2 percentage points from January through July, including 5.5 percentage points from March through May. I’ll be providing my technical view on this stock in our next EB Digest. To sign up for our FREE EB Digest newsletter and receive this specialty finance stock, simply CLICK HERE and provide us your name and email address. There’s no credit card required and you may unsubscribe at any time.

Happy trading!


You May Also Like


Inflation appears to be on the decline. The Personal Consumption Expenditures Price Index (PCEPI), which is the Federal Reserve’s preferred measure of inflation, grew...


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...


On this week’s edition of Stock Talk with Joe Rabil, Joe looks at the longer-term picture for stocks like AAPL, TSLA, and more. He...

Latest News

Kevin McCarthy’s difficult road to becoming House speaker ended early Saturday morning after Republicans appeared to have miscounted the number of votes they needed...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023